All lobbying filings

AEGIS LLC

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Biopharmaceutical industry trade association.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 7, 2026

Official filing document

Bills named in this filing 6

HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
HR 5378
Tribal Healthcare Careers Act
HR 5376
Impacts and Outcomes for Health Career Training Act
HR 6283
FOSTER Act
S 1542
Uyghur Policy Act of 2025
HR 830
SAFE Act

Lobbying activity 2

Pharmacy

Pharmacy Benefit Manager (PBM) issues and reform. 340B. IRA implementation. H.R.1492: Ensuring Pathways to Innovative Cures (EPIC) Act. Drug pricing. Most-Favored Nation (MFN) International reference pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.830 - HELP Copays Act.

Health Issues

General health care issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.